Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study.

Thromb J · 2025 · PMC11780795 · PMID 39885575

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

did not reach statistical significancep = 0.2not close (p > 0.1)

No subjects in the warfarin group developed VTE; however, the numerical difference in efficacy outcomes favouring warfarin over DOAC did not reach statistical significance ( p = 0.2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.